Jennifer Sherr MD, PhDInstructor, Pediatrics (Endocrinology), Yale University School of Medicine, New Haven, Connecticut
Dr. Jennifer Sherr is an Instructor in Pediatrics (endocrinology) at Yale University School of Medicine. She attended the University of Medicine and Dentistry New Jersey-Robert Wood Johnson Medical School and subsequently came to Yale Children’s Hospital to complete her pediatric residency. During her fellowship in endocrinology at Yale University School of Medicine, she was accepted into the Investigate Medicine Program at Yale University Graduate School of Arts & Sciences. The focus of her doctoral thesis was examination of the dysregulated glucagon response early in the course of type 1 diabetes. Subsequently, her research has focused on artificial pancreas technologies and the use of adjunctive therapy to mitigate postprandial hyperglycemia.
MD: University of Medicine and Dentistry New Jersey-Robert Wood Johnson Medical School, New Brunswick, NJ
PhD: Investigative Medicine at Yale University Graduate School of Arts & Sciences
Residency: Yale New Haven Children’s Hospital Residency Program
Fellowship: Yale University School of Medicine Postdoctoral Fellowship in Pediatric Endocrinology and Metabolism
Research Interests: closed loop systems/artificial pancreas technologies, counterregulatory responses to hypoglycemia, use of adjunctive therapy for type 1 diabetes.
Recent Contributions to PracticeUpdate:
- Fixed-Dose Coadministration of Pramlintide Plus Regular Insulin Shows Promise for Postprandial Hyperglycemia
- Insulin Infusion and Glucose Monitoring: A Guideline for Diabetes Technologies
- Improved Glycemic Control With Closed-Loop Insulin in Pregnant Diabetic Women
- Intranasal Glucagon for Insulin-Induced Hypoglycemia in Type 1 Diabetes
- Risk Factors Associated With Mortality During Early Adulthood in Type 1 Diabetes